New appointments to the ACMD
Monday, 3 August 2020 09:55
Experts in topics including clinical toxicology, drug markets,
social research and social care have been appointed to the Advisory
Council on the Misuse of Drugs (ACMD), to help deliver the ACMD’s
vital ongoing work. The ACMD is an independent body which makes
recommendations to government on the control of dangerous or
otherwise harmful drugs, including classification...Request free trial
Experts in topics including clinical toxicology, drug
markets, social research and social care have been
appointed to the Advisory Council on the Misuse of Drugs
(ACMD), to help deliver the ACMD’s vital ongoing work.
The ACMD is an independent body which makes
recommendations to government on the control of
dangerous or otherwise harmful drugs, including
classification and scheduling under the Misuse of Drugs
Act 1971 and its regulations.
The new appointees being announced today are:
- Professor Sarah Galvani, professor of Social
Research and Substance Use at Manchester Metropolitan
University
- Professor Judith Aldridge, professor of criminology
at the University of Manchester
- Dr David Wood, consultant physician and clinical
toxicologist at Guy’s and St Thomas’ Hospital, and
Reader in clinical toxicology at King’s College London
The Chair of the Advisory Council on the Misuse of
Drugs, Professor Owen Bowden-Jones, said:
I am delighted to welcome the new members to the
ACMD. Their range of expertise will ensure that the
Council continues to provide the best possible
evidence-based advice on the harms of drug misuse. I
look forward to working with each of them on a range
of projects.
The 3 appointments to the ACMD will serve 3 year terms.
Appointments to the ACMD attract no remuneration, and
have been made in accordance with the Cabinet Office
Code on Public Appointments.
The newly appointed members take up their positions
today.
|
